Sergio Serafini

Institute of Molecular Biology and Pathology

Papers

Total Citations

H-Index

About

Sergio Serafini is a biochemist whose pioneering work in assay development has advanced antiviral research, particularly in the study of hepatitis C virus (HCV). His most cited contribution, "A High-Throughput Radiometric Assay for Hepatitis C Virus NS3 Protease" (1999), introduced a robust, scalable method for measuring NS3 protease activity—a critical target for HCV therapeutics. This assay enabled rapid screening of potential inhibitors, laying groundwork for later drug discovery efforts. With 14 citations, the paper reflects Serafini’s early impact in creating tools that bridge basic virology and pharmaceutical development. His research focuses on enzymatic mechanisms and high-throughput screening, emphasizing precision and efficiency in biochemical assays. Serafini’s work is notable for its practical application: by simplifying complex protease assays, he empowered labs to accelerate HCV research at a time when the virus posed a global health threat. His contributions resonate in the broader context of antiviral strategy, where reliable assays remain foundational. For students and researchers, Serafini exemplifies how methodical innovation in assay design can catalyze progress against infectious diseases.